Major Depressive Disorder, Panic Disorder, Agoraphobia, Social Anxiety Disorder, Generalized Anxiety Disorder
Conditions
Interventions
12 weeks of Compassion Focused Therapy (60 minutes per session)
Treatment as usual(12 weeks)
Sponsors
National Center for Cognitive Behavior Therapy and Research, National Center of Neurology and Psychiatry
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) Patients with major depressive disorder, panic disorder, agoraphobia, social anxiety disorder, or generalized anxiety disorder in MINI 2) Have more than mild depressive symptoms (14 points or more on BDI-II) 3) Age between 20 and 65 years old at the time of screening
Exclusion criteria
Exclusion criteria: 4) Patients with alcohol or substance dependence within last 6 months 5) Patients with manic episodes, schizophrenia and other psychotic disorders at the time of pre-intervention assessment. 6) Patients who have suicidal ideation at the time of the pre-intervention assessment. 7) Patients with severe physical illness or cognitive impairment at the time of the pre-intervention evaluation. 8) Patients who will be difficult to visit the hospital more than 50%. 9) Patients receiving other structured psychotherapy at the time of the pre-intervention evaluation.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Depressive symptoms as measured by the BDI-II at 13 weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. severity of subjective anxiety symptoms at 13 weeks (GAD-7) 2. severity of subjective depressive symptoms at 13-week (PHQ-9) 3. quality of life at 13 weeks (EQ-5D) 4. treatment response rate at 13-week (13-week BDI-II score reduction of 50% or more compared to baseline) 5. remission rate at 13-week (BDI-II score of 13 or less at 13 weeks) | — |
Countries
Japan
Contacts
Public ContactKenichi Asano
National Center for Cognitive Behavior Therapy and Research National Center for Cognitive Behavior Therapy and Research
Outcome results
None listed